Russell Investments Group
RVMD icon

Russell Investments Group’s Revolution Medicines RVMD Stock Holding History

Russell Investments Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.6M Buy
141,631
+42,514
+43% +$6.21M 0.02% 623
2026
Q1 		$9.64M Buy
99,117
+237
+0.2% +$23.9K 0.01% 961
2025
Q4 		$7.88M Sell
98,880
-25,759
-21% -$1.69M 0.01% 1051
2025
Q3 		$5.82M Sell
124,639
-65,557
-34% -$2.57M 0.01% 1220
2025
Q2 		$7M Sell
190,196
-86,034
-31% -$3.31M 0.01% 1020
2025
Q1 		$9.77M Buy
276,230
+271,987
+6,410% +$11M 0.01% 837
2024
Q4 		$186K Buy
4,243
+434
+11% +$21.9K ﹤0.01% 2556
2024
Q3 		$173K Sell
3,809
-2,233
-37% -$97.2K ﹤0.01% 2544
2024
Q2 		$234K Buy
6,042
+5,694
+1,636% +$213K ﹤0.01% 2439
2024
Q1 		$11.2K Hold
348
– – ﹤0.01% 2837
2023
Q4 		$9.98K Buy
348
+8
+2% +$192 ﹤0.01% 2823
2023
Q3 		$9.41K Hold
340
– – ﹤0.01% 3018
2023
Q2 		$9.1K Hold
340
– – ﹤0.01% 2981
2023
Q1 		$7.36K Buy
+340
New +$8.37K ﹤0.01% 2921
2021
Q3 		– Sell
-8,462
Closed -$268K – 3187
2021
Q2 		$268K Sell
8,462
-23,918
-74% -$835K ﹤0.01% 2813
2021
Q1 		$1.49M Sell
32,380
-16,519
-34% -$741K ﹤0.01% 2047
2020
Q4 		$1.94M Buy
48,899
+40,437
+478% +$1.6M ﹤0.01% 1782
2020
Q3 		$294K Buy
+8,462
New +$234K ﹤0.01% 2621

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Russell Investments Group's RVMD Position: Q2 2026 in Review

Russell Investments Group increased its Revolution Medicines (RVMD) stake by 43% in Q2 2026, buying an estimated $6.21M and bringing the position to 141,631 shares worth $26.6M. The position accounts for 0.02% of the portfolio, ranked #623.

Russell Investments Group first reported a position in RVMD in Q3 2020 and has held it in 18 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Russell Investments Group held 141,631 shares of Revolution Medicines worth $26.6M as of Q2 2026.
  • Russell Investments Group bought 42,514 Revolution Medicines shares in Q2 2026, an estimated $6.21M.
  • Revolution Medicines made up 0.02% of Russell Investments Group's portfolio in Q2 2026, its #623 holding.
  • Russell Investments Group first reported a position in Revolution Medicines in Q3 2020 and has held it in 18 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.